Optimizing Bronchopulmonary Cancer Screening
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50-74
SponsorInstitut Curie
About this trial
The aim of this study is to evaluate the feasibility of performing a first screening for bronchopulmonary cancer by thoracic scanner in a French cohort within a dedicated, effective and structured network in the pilot centers participating in the study.
Eligibility criteria
Qualifiers
Participant aged 50 to 74.
Resident in the Île-de-France region.
more than 10 cigarettes a day for more than 30 years,
more than 15 cigarettes a day for more than 25 years.
Disqualifiers
Active cancer or a history of cancer in remission for less than 5 years (except basal cell carcinoma of th skin or epithelioma in situ of the uterine cervix).
Presence of symptoms suggestive of bronchopulmonary cancer. Participants with these symptoms require immediate diagnostic investigations and are therefore not eligible for screening.
Weight >= 140 kg.
Severe comorbidity contraindicating therapeutic options or invasive thoracic diagnostic investigations.
Trial design
Treatments tested in this trial
- Screening
- Inclusion
- Chest CTscan and follow-up
Treatment groups
500 Participants
are divided into 1 treatment groupSponsors and collaborators
Institut Curie
Lead sponsor
Institut Mutualiste Montsouris
Collaborator
Source ClinicalTrials.gov